Abstract:AIM:Point mutation, one of the commonest gene mutations, is the most important molecular pathogenesis of cancer and chronic infection. The commonest methods for detection of point mutation are based on polymerase chain reaction (PCR). These techniques, however, cannot be used in large scale screening since they are neither accurate nor simple. For this reason, this study established a novel method of competitively differentiated PCR (CD-PCR) for screening point mutation in clinical practice.METHODS:Two competitively differentiated primers for mutant-type and wild-type templates respectively with an identically complemented region in 3' end except for last 2 base pairs and a different non-complemented region in 5' end were designed. Thus, competitive amplification might be carried out at a lower annealing temperature at first, and then differentiated amplification at a higher annealing temperature when primers could not combine with initial templates. The amplification was performed in one-tube. The products of CD-PCR were detected using microplate hybridization assay. CD-PCR was evaluated by detecting G1896A variant of hepatitis B virus (HBV) in form of recombinant plasmids and in sera from patients with hepatitis B, and compared with allele-specific PCR (AS-PCR) and competitive AS-PCR.RESULTS:CD-PCR was successfully established. It could clearly distinguish wild-type and mutant-type plasmid DNA of G1896A variant when the amount of plasmid DNA was between 10(2)-10(8)copies/reaction, while for AS-PCR and competitive AS-PCR, the DNA amount was between 10(2)-10(4)copies/reaction. CD-PCR could detect one copy of G1896A variant among 10-100 copies of wild-type plasmid DNA. The specificity of CD-PCR was higher than those of AS-PCR and competitive AS-PCR in the detection of HBV G1896A variant in sera from patients with hepatitis B. CD-PCR was independent of the amount of HBV DNA in serum. HBV G1896A variant was more often found in HBeAg (-) patients with a lower level of detectable viremia than that with a higher level of detectable viremia (P=0.0192).CONCLUSION:CD-PCR is more specific since it is less influenced by the amount of initial templates and the cross amplification between mutant- and wild-type amplified products. It is also simple and time-saving. Thus, CD-PCR might be useful in routine gene typing and point mutation screening. HBV G1896A or other more important mutations have to be routinely detected in patients with a detectable level of viremia after HBeAg/antibody conversion in clinical practice.

Detection of HBVDNA and HBVcccDNA in Peripheral Blood Mononuclear Cells by a Multiplex Polymerase Chain Reaction

Analysis of suspicious results of serum HBV DNA detected by fluorescence quantitative PCR

The Measurement of HBV DNA in peripheral blood mononuclear cells and its clinical applicability

The Clinical Study on the Detecting Simultaneity HBV DNA in the Serum and Liver Tissuse of Patients with DNA Microarry Technique

[Establishment and Application of Nested Real-Time Quantitative Polymerase Chain Reaction Assay for Detection of Hepatitis B Virus Covalently Closed Circular DNA].

Nested real-time quantitative polymerase chain reaction assay for detection of hepatitis B virus covalently closed circular DNA

Improvement of the Analytical Sensitivity of Domestic HBV DNA Kit Based on Magnetic Beads Nucleic Acid Extraction Method

[A Quantitative Real Time Polymerase Chain Reaction for Detection of HBV Covalently Closed Circular DNA in Livers of the HBV Infected Patients].

Novel Assay of Competitively Differentiated Polymerase Chain Reaction for Screening Point Mutation of Hepatitis B Virus.

Establishment and Application of a Type-Specific Polymerase Chain Reaction(pcr) for HBV Genotyping

Development of a Multiplex PCR Method for Detecting and Typing Human Papillomaviruses in Verrucae Vulgaris

Several Concerns about the Primer Design in the Universal Molecular Beacon Real-Time PCR Assay and Its Application in HBV DNA Detection.

Rapid Detection of Clonal Expansion of T‐cell Receptor‐beta Gene in Patients with HBV Using the Real‐time PCR with DNA Melting Curve Analysis

Multiplex Locked Nucleic Acid Probes for Analysis of Hepatitis B Virus Mutants Using Real-Time PCR

The study on the rolling circle amplification for detecting hepatitis B virus covalently closed circular DNA

Detection of HBV-cccDNA in Hepatic Cells by in Situ PCR

Development and Clinical Validation of a One-Step Pentaplex Real-Time Reverse Transcription PCR Assay for Detection of Hepatitis Virus B, C, E, Treponema Pallidum, and a Human Housekeeping Gene

A sensitive and accurate quantification method for the detection of hepatitis B virus covalently closed circular DNA by the application of a droplet digital polymerase chain reaction amplification system

Establishment and application of a novel PCR assay for amplifying the full-length reverse transcriptase gene region of genotypes A～D of hepatitis B virus

Establishment and Application of a Real-Time PCR Method to Detect Hepatitis B Virus Cccdna Quantitatively

Exonuclease I and III Improve the Detection Efficacy of Hepatitis B Virus Covalently Closed Circular DNA